Treatment | Similarity | Main effects | Pre vs post | Pre vs 4w post | |||
---|---|---|---|---|---|---|---|
p | F | p | F | p | F | ||
TMS | Bray–Curtis | 0.34 | 1.06 | 0.26 | 1.25 | 0.31 | 1.06 |
Jaccard | 0.07 | 1.53 | 0.11 | 1.52 | 0.05 | 1.90 | |
Enrofloxacin PO | Bray–Curtis | 0.002 | 4.11 | 0.001 | 5.86 | 0.006 | 4.51 |
Jaccard | 0.0001 | 15.95 | 0.0001 | 23.71 | 0.0001 | 20.56 | |
Enrofloxacin IP | Bray–Curtis | 0.004 | 3.36 | 0.01 | 4.03 | 0.07 | 2.40 |
Jaccard | 0.0001 | 11.97 | 0.0001 | 16.69 | 0.0001 | 6.09 | |
TAB | Bray–Curtis | 0.0001 | 27.74 | 0.0001 | 40.20 | 0.0005 | 7.16 |
Jaccard | 0.0001 | 20.58 | 0.0001 | 29.25 | 0.0001 | 14.23 | |
Control | Bray–Curtis | 0.35 | 1.06 | 0.44 | 0.87 | 0.30 | 1.09 |
Jaccard | 0.04 | 1.81 | 0.08 | 1.84 | 0.15 | 1.39 |